Corona Remedies Profile
Key Indicators
- Authorised Capital ₹ 61.17 Cr
- Paid Up Capital ₹ 61.16 Cr
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 250.00 Cr
- Satisfied Charges ₹ 112.58 Cr
- Revenue Growth 7.37%
- Profit Growth -100.57%
- Ebitda -83.09%
- Net Worth -5.01%
- Total Assets -3.81%
About Corona Remedies
Corona Remedies Limited (CRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 August 2004 and has a history of 20 years and seven months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 61.17 Cr and a paid-up capital of Rs 61.16 Cr.
The company currently has active open charges totaling ₹250.00 Cr. The company has closed loans amounting to ₹112.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Corona Remedies Limited India are Bhagya Dave as Company Secretary, Bhavin Bhagat as Cfo, and Niravkumar Mehta as Ceo. Ameetkumar Desai, Kshitij Sheth, Ankur Mehta, and Four other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ2004PLC044656
- Company No.
044656
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2004
- Date of AGM
19 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
What products or services does Corona Remedies Limited offer?
Corona Remedies Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Cancer Medicines, Diabetes Medicine, Common Disease Medicines, Pharmaceutical Tablets, Brain & Nervous System Drugs, Antiepileptic Drugs.
Who are the key members and board of directors at Corona Remedies?
Executive Team (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Mehta  | Managing Director | 27-Aug-2004 | Current |
| Nirav Mehta | Managing Director | 30-May-2007 | Current |
| Bhagya Dave | Company Secretary | 11-Nov-2023 | Current |
| Bhavin Bhagat | CFO | 29-Oct-2024 | Current |
| Niravkumar Mehta | CEO | 04-Sep-2024 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kshitij Sheth | Nominee Director | 30-Mar-2021 | Current |
| Ameetkumar Desai | Director | 22-Nov-2022 | Current |
| Kirtikumar Mehta | Director | 27-Aug-2004 | Current |
| Viral Sitwala | Whole-Time Director | 01-Jan-2010 | Current |
| Monica Kanuga | Director | 24-Oct-2024 | Current |
Financial Performance of Corona Remedies.
Corona Remedies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.37% increase. The company also saw a substantial fall in profitability, with a 100.57% decrease in profit. The company's net worth dipped by a decrease of 5.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corona Remedies?
In 2024, Corona Remedies had a promoter holding of 72.50% and a public holding of 27.50%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sourcepro Infotech Private LimitedAmeetkumar Desai is a mutual person
Ambuja Cements LimitedAmeetkumar Desai is a mutual person
Jm Financial Asset Reconstruction Company LimitedAmeetkumar Desai is a mutual person
La Renon Healthcare Private LimitedKshitij Sheth is a mutual person
Shilp Gravures LimitedMonica Kanuga is a mutual person
Globalbees Brands Private LimitedKshitij Sheth is a mutual person
Charges (Loans)
Open Charges
₹250.00 Cr
Satisfied Charges
₹112.58 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 200.00 Cr
- Others : 50.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2023 | Others | ₹50.00 Cr | Open |
| 07 Jul 2023 | Citi Bank N.A. | ₹200.00 Cr | Open |
| 28 Aug 2019 | Others | ₹3.28 M | Satisfied |
| 22 Aug 2019 | Others | ₹6.06 M | Satisfied |
| 02 Feb 2019 | Hdfc Bank Limited | ₹50.00 Cr | Satisfied |
How Many Employees Work at Corona Remedies?
Corona Remedies has a workforce of 4223 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corona Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corona Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Corona Remedies
Recent activity within the organization
- Director Appointment
Bhavin Nareshbhai Bhagat was appointed as a Cfo was appointed as a Cfo on 29 Oct 2024 & has been associated with this company since 4 months 29 days .
- Director Appointment
Monica Hemal Kanuga was appointed as a Director was appointed as a Director on 24 Oct 2024 & has been associated with this company since 5 months 3 days .
- Director Appointment
Niravkumar Kirtikumar Mehta was appointed as a Ceo was appointed as a Ceo on 04 Sep 2024 & has been associated with this company since 6 months 23 days .
- Annual General Meeting
Corona Remedies Limited last Annual general meeting of members was held on 19 Jun 2024 as per latest MCA records.
- Charges
A charge with Citi Bank N.A. of Rs. 200.00 Cr registered on 07 Jul 2023 with Charge ID 100749708 was modified on 01 Apr 2024.
- Balance Sheet
Corona Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Recent News, Updates & Announcement
- Corona Acquires Myoril from Sanofi India for Rs234 Crore, Boosting Indian Pharma Industry's Growth.
CORONA Remedies bought Myoril from Sanofi India for Rs234 crore. Sanofi sold it to focus on chronic diseases. Corona also bought other brands before. Myoril is worth Rs38 crore and growing at 6.8%. Sanofi also sold other brands to different companies. Indian pharma industry is growing at 10% and expected to reach Rs2,95,100 crore by 2026. E-pharmacy and new regulations will help it grow..
Frequently asked questions
What is the Incorporation or founding date of Corona Remedies Limited?
Corona Remedies Limited was incorporated on 27 Aug 2004.
What is authorized share capital and paid-up capital of Corona Remedies Limited?
The authorized share capital of Corona Remedies Limited is ₹ 61.17 Cr and paid-up capital is ₹ 61.16 Cr.
Who are the current board members & directors of Corona Remedies Limited?
Currently 10 directors are associated with Corona Remedies Limited.
- Ameetkumar Hiranyakumar Desai
- Kshitij Pankaj Sheth
- Ankur Kirtikumar Mehta
- Kirtikumar Laxmidas Mehta
- Nirav Kirtikumar Mehta
- Viral Bhupendrabhai Sitwala
- Monica Hemal Kanuga
- Bhagya Kapilbhai Dave
- Bhavin Nareshbhai Bhagat
- Niravkumar Kirtikumar Mehta
What is the registered address of Corona Remedies Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Corona Remedies Limited is Corona House C-Mondeal Business Park Near Gurudwara S. G. Highway, Thaltej India, Ahmedabad, Gujarat, 380054.
What is the corporate identification number (CIN) and company number of Corona Remedies Limited?
The corporate identification number (CIN) of Corona Remedies Limited is U24231GJ2004PLC044656 and the company number is 044656 as per Ministry of Corporate Affairs (MCA).
What is the official website of Corona Remedies Limited?
The Official website of Corona Remedies Limited is https://www.coronaremedies.com
What has been the recent revenue trend for Corona Remedies Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Corona Remedies Limited has risen by 7.37%.
How many employees does Corona Remedies Limited currently have?
As Per 2022 financial reports, 4223 employees are currently employed by Corona Remedies Limited.
What change has been observed in the net worth of Corona Remedies Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Corona Remedies Limited has experienced an downturn of -5.01%.
What are the total open charges for Corona Remedies Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Corona Remedies Limited amount to ₹ 250.00 Cr.
When was the last Balance Sheet of Corona Remedies Limited filed with the ROC?
The most recent Balance Sheet for Corona Remedies Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Akash JainNominee DirectorDM
Dipaben MehtaDirectorBM
Brinda MehtaDirectorMM
Minaxi MehtaDirector